Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2020

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. HOOD
10. IBM

Go back to Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2020

Enanta Pharma (ENTA) Misses Q4 EPS by 51c

November 23, 2020 4:01 PM EST

Enanta Pharma (NASDAQ: ENTA) reported Q4 EPS of ($1.46), $0.51 worse than the analyst estimate of ($0.95). Revenue for the quarter came in at $23.6 million versus the consensus estimate of $25.74 million.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.

... More